Serge Verstovsek, MD Discusses Myelofibrosis and Thrombocytosis

Serge Verstovsek, MD

At the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Rare Disease Report sat down with Serge Verstovsek, MD of the MD Anderson Cancer Center to discuss myelofibrosis and thrombocytosis, and the potential treatment options for both with the therapies ruxolitinib and azacytidine.

Among the questions asked were:
For more from ASCO, check out our Conference Coverage page.
Printer Printing...